| 000 | 01835 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513061735.0 | ||
| 264 | 0 | _c19940328 | |
| 008 | 199403s 0 0 eng d | ||
| 022 | _a0022-3565 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBertolino, F | |
| 245 | 0 | 0 |
_aPrevention of thromboxane A2 receptor-mediated pulmonary hypertension by a nonpeptide angiotensin II type 1 receptor antagonist. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cFeb 1994 |
||
| 300 |
_a747-52 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _a15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid |
| 650 | 0 | 4 |
_aAngiotensin II _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAngiotensin Receptor Antagonists |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xpharmacology |
| 650 | 0 | 4 |
_aBiphenyl Compounds _xpharmacology |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 | _aBridged Bicyclo Compounds, Heterocyclic |
| 650 | 0 | 4 |
_aEnalapril _xpharmacology |
| 650 | 0 | 4 | _aFatty Acids, Unsaturated |
| 650 | 0 | 4 | _aHematocrit |
| 650 | 0 | 4 |
_aHydrazines _xpharmacology |
| 650 | 0 | 4 |
_aHypertension, Pulmonary _xetiology |
| 650 | 0 | 4 |
_aImidazoles _xpharmacology |
| 650 | 0 | 4 | _aLosartan |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aProstaglandin Endoperoxides, Synthetic _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptors, Thromboxane _xphysiology |
| 650 | 0 | 4 |
_aTetrazoles _xpharmacology |
| 650 | 0 | 4 |
_aThromboxane A2 _xanalogs & derivatives |
| 700 | 1 | _aValentin, J P | |
| 700 | 1 | _aMaffre, M | |
| 700 | 1 | _aJover, B | |
| 700 | 1 | _aBessac, A M | |
| 700 | 1 | _aJohn, G W | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 268 _gno. 2 _gp. 747-52 |
|
| 999 |
_c8113311 _d8113311 |
||